195 related articles for article (PubMed ID: 9628657)
1. Effect of the selective phosphodiesterase type 5 inhibitor sildenafil on erectile dysfunction in the anesthetized dog.
Carter AJ; Ballard SA; Naylor AM
J Urol; 1998 Jul; 160(1):242-6. PubMed ID: 9628657
[TBL] [Abstract][Full Text] [Related]
2. Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway.
McAuley IW; Kim NN; Min K; Goldstein I; Traish AM
J Androl; 2001; 22(4):623-8. PubMed ID: 11451359
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological profiles of sildenafil (VIAGRA) in the treatment of erectile dysfunction: efficacy and drug interaction with nitrate].
Omote M
Nihon Yakurigaku Zasshi; 1999 Oct; 114(4):213-8. PubMed ID: 10584234
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of vardenafil and sildenafil in facilitating penile erection in an animal model.
Choi S; O'Connell L; Min K; Kim NN; Munarriz R; Goldstein I; Bischoff E; Traish AM
J Androl; 2002; 23(3):332-7. PubMed ID: 12002434
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of penile tumescence by T-1032, a new potent and specific phosphodiesterase type V inhibitor, in dogs.
Noto T; Inoue H; Ikeo T; Kikkawa K
J Pharmacol Exp Ther; 2000 Sep; 294(3):870-5. PubMed ID: 10945835
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
[TBL] [Abstract][Full Text] [Related]
7. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.
Gur S; Kadowitz PJ; Gurkan L; Chandra S; Dewitt SY; Harbin A; Sikka SC; Agrawal KC; Hellstrom WJ
BJU Int; 2010 Jul; 106(1):78-83. PubMed ID: 20002674
[TBL] [Abstract][Full Text] [Related]
8. Optimizing nitric oxide production by time dependent L-arginine administration in isolated human corpus cavernosum.
Gur S; Kadowitz PJ; Trost L; Hellstrom WJ
J Urol; 2007 Oct; 178(4 Pt 1):1543-8. PubMed ID: 17707054
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology of sildenafil, a novel and selective inhibitor of phosphodiesterase (PDE) type 5.
Wallis RM
Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():22P-26P. PubMed ID: 10629850
[TBL] [Abstract][Full Text] [Related]
10. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.
Ballard SA; Gingell CJ; Tang K; Turner LA; Price ME; Naylor AM
J Urol; 1998 Jun; 159(6):2164-71. PubMed ID: 9598563
[TBL] [Abstract][Full Text] [Related]
11. Clinical and duplex US assessment of effects of sildenafil on cavernosal arteries of the penis: comparison with intracavernosal injection of vasoactive agents--initial experience.
Copel L; Katz R; Blachar A; Sosna J; Sheiman RG
Radiology; 2005 Dec; 237(3):986-91. PubMed ID: 16237136
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ-10258859.
Qiu Y; Bhattacharjee S; Kraft P; John TM; Craig E; Haynes-Johnson D; Guan J; Jiang W; Macielag M; Sui Z; Clancy J; Lundeen S
Eur J Pharmacol; 2003 Jul; 472(1-2):73-80. PubMed ID: 12860475
[TBL] [Abstract][Full Text] [Related]
13. Nebivolol dilates human penile arteries and reverses erectile dysfunction in diabetic rats through enhancement of nitric oxide signaling.
Angulo J; Wright HM; Cuevas P; González-Corrochano R; Fernández A; Cuevas B; La Fuente JM; Gupta S; Sáenz de Tejada I
J Sex Med; 2010 Aug; 7(8):2681-97. PubMed ID: 20214719
[TBL] [Abstract][Full Text] [Related]
14. FR226807: a potent and selective phosphodiesterase type 5 inhibitor.
Hosogai N; Hamada K; Tomita M; Nagashima A; Takahashi T; Sekizawa T; Mizutani T; Urano Y; Kuroda A; Sawada K; Ozaki T; Seki J; Goto T
Eur J Pharmacol; 2001 Oct; 428(2):295-302. PubMed ID: 11675048
[TBL] [Abstract][Full Text] [Related]
15. Erection capability is potentiated by long-term sildenafil treatment: role of blood flow-induced endothelial nitric-oxide synthase phosphorylation.
Musicki B; Champion HC; Becker RE; Liu T; Kramer MF; Burnett AL
Mol Pharmacol; 2005 Jul; 68(1):226-32. PubMed ID: 15851653
[TBL] [Abstract][Full Text] [Related]
16. Effect of sildenafil on non-adrenergic non-cholinergic neurotransmission in bovine penile small arteries.
Simonsen U; Contreras J; García-Sacristán A; Martinez AC
Eur J Pharmacol; 2001 Jan; 412(2):155-69. PubMed ID: 11165227
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Cyclic GMP Export by Multidrug Resistance Protein 4: A New Strategy to Treat Erectile Dysfunction?
Boydens C; Pauwels B; Vanden Daele L; Van de Voorde J
J Sex Med; 2017 Apr; 14(4):502-509. PubMed ID: 28258955
[TBL] [Abstract][Full Text] [Related]
18. Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats.
Doherty PC; Bivalacqua TJ; Champion HC; Kadowitz PJ; Greenwood-Van Meerveld B; Berzetei-Gurske I; Hellstrom WJ
J Urol; 2001 Mar; 165(3):1004-9. PubMed ID: 11176530
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction.
Goldenberg MM
Clin Ther; 1998; 20(6):1033-48. PubMed ID: 9916601
[TBL] [Abstract][Full Text] [Related]
20. T-0156, a novel phosphodiesterase type 5 inhibitor, and sildenafil have different pharmacological effects on penile tumescence and electroretinogram in dogs.
Mochida H; Noto T; Inoue H; Yano K; Kikkawa K
Eur J Pharmacol; 2004 Feb; 485(1-3):283-8. PubMed ID: 14757152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
